瑞格列奈/睡前中性鱼精蛋白锌胰岛素与一日两次中性鱼精蛋白锌胰岛素相当。 - Suppr

Suppr

超能文献

Repaglinide/bedtime NPH insulin is comparable to twice-daily NPH insulin.

作者信息

Panelo Araceli, Wing Jeffrey Robert

机构信息

Department of Medicine, Amang Rodriguez Medical Centre, Marikina City 1800, Philippines.

出版信息

Diabetes Care. 2005 Jul;28(7):1789-90. doi: 10.2337/diacare.28.7.1789.

DOI:10.2337/diacare.28.7.1789

PMID:15983336

Abstract

摘要

相似文献

Repaglinide/bedtime NPH insulin is comparable to twice-daily NPH insulin.

Diabetes Care. 2005 Jul;28(7):1789-90. doi: 10.2337/diacare.28.7.1789.

Effect of repaglinide addition to NPH insulin monotherapy on glycemic control in patients with type 2 diabetes.

Diabetes Care. 2001 Oct;24(10):1844-5. doi: 10.2337/diacare.24.10.1844.

Safety and efficacy of repaglinide in combination with metformin and bedtime NPH insulin as an insulin treatment regimen in type 2 diabetes.

Diabetes Res Clin Pract. 2008 Jan;79(1):42-7. doi: 10.1016/j.diabres.2007.07.001. Epub 2007 Aug 21.

Repaglinide versus metformin in combination with bedtime NPH insulin in patients with type 2 diabetes established on insulin/metformin combination therapy.

Diabetes Care. 2002 Oct;25(10):1685-90. doi: 10.2337/diacare.25.10.1685.

Comparison of repaglinide vs. gliclazide in combination with bedtime NPH insulin in patients with Type 2 diabetes inadequately controlled with oral hypoglycaemic agents.

Diabet Med. 2003 Nov;20(11):935-41. doi: 10.1046/j.1464-5491.2003.01053.x.

Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes.

Diabetes Res Clin Pract. 2003 Nov;62(2):79-86. doi: 10.1016/s0168-8227(03)00167-0.

Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy.

Diabetes Care. 2004 Feb;27(2):632-3. doi: 10.2337/diacare.27.2.632.

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Diabetes Care. 2000 Aug;23(8):1130-6. doi: 10.2337/diacare.23.8.1130.

Repaglinide improves blood glucose control in sulphonylurea-naive type 2 diabetes.

Diabetes Res Clin Pract. 2001 Sep;53(3):141-8. doi: 10.1016/s0168-8227(01)00253-4.

Metformin/Repaglinide (PrandiMet) for type 2 diabetes.

Med Lett Drugs Ther. 2009 Jun 1;51(1313):41-3.

引用本文的文献

Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.

Nat Rev Endocrinol. 2016 Oct;12(10):566-92. doi: 10.1038/nrendo.2016.86. Epub 2016 Jun 24.

The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus.

Arch Med Sci. 2013 Oct 31;9(5):936-43. doi: 10.5114/aoms.2013.34991. Epub 2013 Apr 30.

The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients.

J Endocrinol Invest. 2009 Jan;32(1):69-73. doi: 10.1007/BF03345682.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Repaglinide/bedtime NPH insulin is comparable to twice-daily NPH insulin.

作者信息

Panelo Araceli, Wing Jeffrey Robert

机构信息

Department of Medicine, Amang Rodriguez Medical Centre, Marikina City 1800, Philippines.

出版信息

Diabetes Care. 2005 Jul;28(7):1789-90. doi: 10.2337/diacare.28.7.1789.

DOI:10.2337/diacare.28.7.1789

PMID:15983336

Abstract

摘要